AstraZeneca has reported positive full results from its phase 3 NATRON trial evaluating Fasenra (benralizumab) for the ...

Amgen has reported positive results from its phase 3 VESALIUS-CV trial, which demonstrated that Repatha (evolocumab) ...

Scientists at the University of Edinburgh have identified new drug targets within bacterial cells that could help overcome ...

Merck (known as MSD outside the United States and Canada) has ended its development partnership with Dr Falk Pharma ...

Lilly will also gain exclusive access to MeiraGTx’s gene therapy platform technologies, including novel intravitreal capsids ...

Smurfit Westrock has inaugurated the first-of-its-kind adherence and clinical packaging facility, reinforcing Ireland’s role ...

Support for first and only high-risk smouldering multiple myeloma treatment came from positive phase 3 trial results ...

AstraZeneca has announced positive results from its Bax24 trial of baxdrostat, an investigational treatment for hypertension, ...

The new wave of GenAI-powered search tools now offers researchers an alternative method for accessing insights at speed ...

As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies can ...

At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, ...

Merck (known as MSD outside the US and Canada) has entered into a funding agreement with Blackstone Life Sciences to support ...